A randomized, double-blind, placebo-controlled phase II study of eculizumab in patients with refractory generalized myasthenia gravis

Stopping Seizures Early and the Surgical Epilepsy Trial That Stopped Even Earlier

(2012) Donald L. Schomer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Complement and cytokine based therapeutic strategies in myasthenia gravis

(2011) Erdem Tüzün et al.   JOURNAL OF AUTOIMMUNITY

MG-ADL: Still a relevant outcome measure

(2011) Srikanth Muppidi et al.   MUSCLE & NERVE

Current and emerging therapies for the treatment of myasthenia gravis

(2011) Renato Mantegazza   Neuropsychiatric Disease and Treatment

Responder Analyses—A PhRMA Position Paper

(2011) Tom Uryniak et al.   Statistics in Biopharmaceutical Research

Correlation of C3 level with severity of generalized myasthenia gravis

(2009) Aidong Liu et al.   MUSCLE & NERVE

Rituximab in the management of refractory myasthenia gravis

(2009) Nazlee Zebardast et al.   MUSCLE & NERVE

Incidence and mortality rates of myasthenia gravis and myasthenic crisis in US hospitals

(2009) A. Alshekhlee et al.   NEUROLOGY

Current and future standards in treatment of myasthenia gravis

(2008) Ralf Gold et al.   Neurotherapeutics

Lifetime course of myasthenia gravis

(2007) David Grob et al.   MUSCLE & NERVE